nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—BCHE—peripheral nervous system neoplasm	0.75	1	CbGaD
Ramipril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.00624	0.348	CbGeAlD
Ramipril—ACE—forelimb—peripheral nervous system neoplasm	0.00314	0.175	CbGeAlD
Ramipril—ACE—arm—peripheral nervous system neoplasm	0.0027	0.15	CbGeAlD
Ramipril—ACE—nerve—peripheral nervous system neoplasm	0.00172	0.0958	CbGeAlD
Ramipril—ACE—ganglion—peripheral nervous system neoplasm	0.00169	0.0946	CbGeAlD
Ramipril—Perindopril—BCHE—peripheral nervous system neoplasm	0.00142	0.428	CrCbGaD
Ramipril—SLC15A2—parotid gland—peripheral nervous system neoplasm	0.000685	0.0382	CbGeAlD
Ramipril—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000615	0.0343	CbGeAlD
Ramipril—Perindopril—ABCB1—peripheral nervous system neoplasm	0.000556	0.168	CrCbGaD
Ramipril—BCHE—brainstem—peripheral nervous system neoplasm	0.000544	0.0304	CbGeAlD
Ramipril—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.00049	0.148	CrCbGaD
Ramipril—Lisinopril—ABCB1—peripheral nervous system neoplasm	0.00049	0.148	CrCbGaD
Ramipril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.000359	0.109	CrCbGaD
Ramipril—SLC15A2—cerebellum—peripheral nervous system neoplasm	0.000317	0.0177	CbGeAlD
Ramipril—BCHE—cerebellum—peripheral nervous system neoplasm	0.000268	0.015	CbGeAlD
Ramipril—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00013	0.000569	CcSEcCtD
Ramipril—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000568	CcSEcCtD
Ramipril—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000567	CcSEcCtD
Ramipril—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000567	CcSEcCtD
Ramipril—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000565	CcSEcCtD
Ramipril—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000561	CcSEcCtD
Ramipril—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000128	0.000561	CcSEcCtD
Ramipril—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000559	CcSEcCtD
Ramipril—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000558	CcSEcCtD
Ramipril—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000557	CcSEcCtD
Ramipril—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.000556	CcSEcCtD
Ramipril—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000555	CcSEcCtD
Ramipril—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000554	CcSEcCtD
Ramipril—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000551	CcSEcCtD
Ramipril—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000126	0.00055	CcSEcCtD
Ramipril—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000549	CcSEcCtD
Ramipril—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000542	CcSEcCtD
Ramipril—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.000541	CcSEcCtD
Ramipril—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000539	CcSEcCtD
Ramipril—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000536	CcSEcCtD
Ramipril—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000536	CcSEcCtD
Ramipril—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000536	CcSEcCtD
Ramipril—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000122	0.000535	CcSEcCtD
Ramipril—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000533	CcSEcCtD
Ramipril—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000531	CcSEcCtD
Ramipril—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000529	CcSEcCtD
Ramipril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000529	CcSEcCtD
Ramipril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000121	0.000528	CcSEcCtD
Ramipril—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000528	CcSEcCtD
Ramipril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000526	CcSEcCtD
Ramipril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00012	0.000524	CcSEcCtD
Ramipril—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000119	0.000523	CcSEcCtD
Ramipril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000522	CcSEcCtD
Ramipril—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000119	0.000521	CcSEcCtD
Ramipril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000517	CcSEcCtD
Ramipril—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000516	CcSEcCtD
Ramipril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000515	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000512	CcSEcCtD
Ramipril—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.000512	CcSEcCtD
Ramipril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000117	0.000511	CcSEcCtD
Ramipril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000509	CcSEcCtD
Ramipril—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000508	CcSEcCtD
Ramipril—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000116	0.000508	CcSEcCtD
Ramipril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000507	CcSEcCtD
Ramipril—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000116	0.000507	CcSEcCtD
Ramipril—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000507	CcSEcCtD
Ramipril—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000504	CcSEcCtD
Ramipril—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000504	CcSEcCtD
Ramipril—Constipation—Etoposide—peripheral nervous system neoplasm	0.000115	0.000503	CcSEcCtD
Ramipril—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000502	CcSEcCtD
Ramipril—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000502	CcSEcCtD
Ramipril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000502	CcSEcCtD
Ramipril—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000498	CcSEcCtD
Ramipril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000498	CcSEcCtD
Ramipril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000113	0.000497	CcSEcCtD
Ramipril—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000496	CcSEcCtD
Ramipril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00049	CcSEcCtD
Ramipril—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000489	CcSEcCtD
Ramipril—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000488	CcSEcCtD
Ramipril—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000488	CcSEcCtD
Ramipril—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000485	CcSEcCtD
Ramipril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000111	0.000485	CcSEcCtD
Ramipril—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00011	0.000483	CcSEcCtD
Ramipril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000482	CcSEcCtD
Ramipril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00011	0.000481	CcSEcCtD
Ramipril—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00011	0.00048	CcSEcCtD
Ramipril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000479	CcSEcCtD
Ramipril—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000475	CcSEcCtD
Ramipril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000475	CcSEcCtD
Ramipril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000474	CcSEcCtD
Ramipril—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000473	CcSEcCtD
Ramipril—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000472	CcSEcCtD
Ramipril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00047	CcSEcCtD
Ramipril—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000469	CcSEcCtD
Ramipril—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000107	0.000467	CcSEcCtD
Ramipril—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000466	CcSEcCtD
Ramipril—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000466	CcSEcCtD
Ramipril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000106	0.000465	CcSEcCtD
Ramipril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000106	0.000465	CcSEcCtD
Ramipril—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000465	CcSEcCtD
Ramipril—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000465	CcSEcCtD
Ramipril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000464	CcSEcCtD
Ramipril—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000105	0.000462	CcSEcCtD
Ramipril—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000461	CcSEcCtD
Ramipril—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000458	CcSEcCtD
Ramipril—Rash—Vincristine—peripheral nervous system neoplasm	0.000105	0.000458	CcSEcCtD
Ramipril—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000104	0.000457	CcSEcCtD
Ramipril—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000457	CcSEcCtD
Ramipril—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000456	CcSEcCtD
Ramipril—Headache—Vincristine—peripheral nervous system neoplasm	0.000104	0.000455	CcSEcCtD
Ramipril—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000452	CcSEcCtD
Ramipril—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000451	CcSEcCtD
Ramipril—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000449	CcSEcCtD
Ramipril—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000447	CcSEcCtD
Ramipril—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000447	CcSEcCtD
Ramipril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000446	CcSEcCtD
Ramipril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000439	CcSEcCtD
Ramipril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000439	CcSEcCtD
Ramipril—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.9e-05	0.000433	CcSEcCtD
Ramipril—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000433	CcSEcCtD
Ramipril—Nausea—Vincristine—peripheral nervous system neoplasm	9.85e-05	0.000431	CcSEcCtD
Ramipril—Flushing—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000431	CcSEcCtD
Ramipril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000429	CcSEcCtD
Ramipril—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000423	CcSEcCtD
Ramipril—Asthenia—Etoposide—peripheral nervous system neoplasm	9.64e-05	0.000422	CcSEcCtD
Ramipril—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000422	CcSEcCtD
Ramipril—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.000419	CcSEcCtD
Ramipril—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000418	CcSEcCtD
Ramipril—Pruritus—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.000416	CcSEcCtD
Ramipril—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	9.47e-05	0.000414	CcSEcCtD
Ramipril—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000414	CcSEcCtD
Ramipril—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.00041	CcSEcCtD
Ramipril—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.32e-05	0.000408	CcSEcCtD
Ramipril—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000406	CcSEcCtD
Ramipril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000406	CcSEcCtD
Ramipril—Rash—Cisplatin—peripheral nervous system neoplasm	9.24e-05	0.000405	CcSEcCtD
Ramipril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.24e-05	0.000404	CcSEcCtD
Ramipril—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000404	CcSEcCtD
Ramipril—Erythema—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000404	CcSEcCtD
Ramipril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.19e-05	0.000402	CcSEcCtD
Ramipril—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.0004	CcSEcCtD
Ramipril—Flushing—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000398	CcSEcCtD
Ramipril—Tension—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000396	CcSEcCtD
Ramipril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000396	CcSEcCtD
Ramipril—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000392	CcSEcCtD
Ramipril—Dizziness—Etoposide—peripheral nervous system neoplasm	8.88e-05	0.000389	CcSEcCtD
Ramipril—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000388	CcSEcCtD
Ramipril—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000388	CcSEcCtD
Ramipril—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000387	CcSEcCtD
Ramipril—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000384	CcSEcCtD
Ramipril—Nausea—Cisplatin—peripheral nervous system neoplasm	8.71e-05	0.000381	CcSEcCtD
Ramipril—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000379	CcSEcCtD
Ramipril—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000376	CcSEcCtD
Ramipril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.000375	CcSEcCtD
Ramipril—Vomiting—Etoposide—peripheral nervous system neoplasm	8.54e-05	0.000374	CcSEcCtD
Ramipril—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000374	CcSEcCtD
Ramipril—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000374	CcSEcCtD
Ramipril—Agitation—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000371	CcSEcCtD
Ramipril—Rash—Etoposide—peripheral nervous system neoplasm	8.47e-05	0.000371	CcSEcCtD
Ramipril—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.00037	CcSEcCtD
Ramipril—Headache—Etoposide—peripheral nervous system neoplasm	8.41e-05	0.000368	CcSEcCtD
Ramipril—Tension—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000367	CcSEcCtD
Ramipril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000366	CcSEcCtD
Ramipril—Malaise—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000364	CcSEcCtD
Ramipril—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000363	CcSEcCtD
Ramipril—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000363	CcSEcCtD
Ramipril—Syncope—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000362	CcSEcCtD
Ramipril—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000362	CcSEcCtD
Ramipril—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000359	CcSEcCtD
Ramipril—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.000357	CcSEcCtD
Ramipril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000355	CcSEcCtD
Ramipril—Cough—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000352	CcSEcCtD
Ramipril—Convulsion—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.00035	CcSEcCtD
Ramipril—Nausea—Etoposide—peripheral nervous system neoplasm	7.98e-05	0.000349	CcSEcCtD
Ramipril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000347	CcSEcCtD
Ramipril—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000344	CcSEcCtD
Ramipril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000344	CcSEcCtD
Ramipril—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000344	CcSEcCtD
Ramipril—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000343	CcSEcCtD
Ramipril—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000343	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000341	CcSEcCtD
Ramipril—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.00034	CcSEcCtD
Ramipril—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000337	CcSEcCtD
Ramipril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000336	CcSEcCtD
Ramipril—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000336	CcSEcCtD
Ramipril—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000335	CcSEcCtD
Ramipril—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000335	CcSEcCtD
Ramipril—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000332	CcSEcCtD
Ramipril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.00033	CcSEcCtD
Ramipril—Oedema—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.00033	CcSEcCtD
Ramipril—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.00033	CcSEcCtD
Ramipril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000328	CcSEcCtD
Ramipril—Cough—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000326	CcSEcCtD
Ramipril—Shock—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000324	CcSEcCtD
Ramipril—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000324	CcSEcCtD
Ramipril—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000323	CcSEcCtD
Ramipril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000323	CcSEcCtD
Ramipril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000322	CcSEcCtD
Ramipril—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.00032	CcSEcCtD
Ramipril—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000319	CcSEcCtD
Ramipril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000318	CcSEcCtD
Ramipril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000318	CcSEcCtD
Ramipril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000318	CcSEcCtD
Ramipril—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000317	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000316	CcSEcCtD
Ramipril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000314	CcSEcCtD
Ramipril—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000314	CcSEcCtD
Ramipril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000311	CcSEcCtD
Ramipril—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000308	CcSEcCtD
Ramipril—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000308	CcSEcCtD
Ramipril—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000305	CcSEcCtD
Ramipril—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000305	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.0003	CcSEcCtD
Ramipril—Shock—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.0003	CcSEcCtD
Ramipril—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000299	CcSEcCtD
Ramipril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000299	CcSEcCtD
Ramipril—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.81e-05	0.000298	CcSEcCtD
Ramipril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000298	CcSEcCtD
Ramipril—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000296	CcSEcCtD
Ramipril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000296	CcSEcCtD
Ramipril—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000295	CcSEcCtD
Ramipril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000294	CcSEcCtD
Ramipril—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000293	CcSEcCtD
Ramipril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000291	CcSEcCtD
Ramipril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.00029	CcSEcCtD
Ramipril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.000287	CcSEcCtD
Ramipril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000285	CcSEcCtD
Ramipril—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000285	CcSEcCtD
Ramipril—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000284	CcSEcCtD
Ramipril—Constipation—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000282	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000278	CcSEcCtD
Ramipril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000276	CcSEcCtD
Ramipril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000274	CcSEcCtD
Ramipril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000272	CcSEcCtD
Ramipril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000272	CcSEcCtD
Ramipril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000271	CcSEcCtD
Ramipril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.00027	CcSEcCtD
Ramipril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000268	CcSEcCtD
Ramipril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000265	CcSEcCtD
Ramipril—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000263	CcSEcCtD
Ramipril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000263	CcSEcCtD
Ramipril—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000262	CcSEcCtD
Ramipril—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000261	CcSEcCtD
Ramipril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000261	CcSEcCtD
Ramipril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000261	CcSEcCtD
Ramipril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000251	CcSEcCtD
Ramipril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000249	CcSEcCtD
Ramipril—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000243	CcSEcCtD
Ramipril—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000242	CcSEcCtD
Ramipril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000241	CcSEcCtD
Ramipril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000241	CcSEcCtD
Ramipril—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000237	CcSEcCtD
Ramipril—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000233	CcSEcCtD
Ramipril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000226	CcSEcCtD
Ramipril—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000225	CcSEcCtD
Ramipril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000219	CcSEcCtD
Ramipril—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000218	CcSEcCtD
Ramipril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000216	CcSEcCtD
Ramipril—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.00021	CcSEcCtD
Ramipril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000209	CcSEcCtD
Ramipril—Rash—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000208	CcSEcCtD
Ramipril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000208	CcSEcCtD
Ramipril—Headache—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000207	CcSEcCtD
Ramipril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000202	CcSEcCtD
Ramipril—Nausea—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000196	CcSEcCtD
Ramipril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000194	CcSEcCtD
Ramipril—Rash—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000192	CcSEcCtD
Ramipril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000192	CcSEcCtD
Ramipril—Headache—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000191	CcSEcCtD
Ramipril—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.000181	CcSEcCtD
